19-51496927-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_053003.4(SIGLEC12):c.1552G>A(p.Asp518Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053003.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIGLEC12 | ENST00000291707.8 | c.1552G>A | p.Asp518Asn | missense_variant | Exon 7 of 8 | 1 | NM_053003.4 | ENSP00000291707.3 | ||
SIGLEC12 | ENST00000596742.1 | n.*767G>A | non_coding_transcript_exon_variant | Exon 7 of 8 | 1 | ENSP00000469791.1 | ||||
SIGLEC12 | ENST00000596742.1 | n.*767G>A | 3_prime_UTR_variant | Exon 7 of 8 | 1 | ENSP00000469791.1 | ||||
SIGLEC12 | ENST00000598614.1 | c.1198G>A | p.Asp400Asn | missense_variant | Exon 6 of 7 | 5 | ENSP00000472873.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251484 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461524Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727058 show subpopulations
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74464 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1552G>A (p.D518N) alteration is located in exon 7 (coding exon 7) of the SIGLEC12 gene. This alteration results from a G to A substitution at nucleotide position 1552, causing the aspartic acid (D) at amino acid position 518 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at